BRD2 and polycystic ovary syndrome: Outcomes included reduced sperm motility and concentration, increased risk of PCOS, infertility, spontaneous abortion, decreased ovarian reserve, poorer embryo quality in IVF, altered hormone levels (estradiol, E2; luteinizing hormone, LH; follicle-stimulating hormone, FSH), and earlier menopause.